Orlando, FL – According to filings with the U.S. Securities and Exchange Commission, Enveda Therapeutics is raising $4,999,998.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Viswa Colluru played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Enveda Therapeutics

At Enveda, we’re constructing and decoding the largest integrated dataset of anthropological, biological, and chemical information from medicinal plants to inspire new medicines. Our platform is systematizing the discovery of drugs like Aspirin, Quinine, Metformin, and CBD by intelligently probing the “dark” bio-chemical space of medicinal plants which humanity has narrowed over millennia of trial and error. We’re uncovering safe molecules with remarkable pharmacology that will herald a new generation of drugs from the roots of medicine itself. The possibilities are endless from new antibiotics to hypotensives.

To learn more about Enveda Therapeutics, visit http://envedatherapeutics.com/

Contact:
Viswa Colluru, Chief Executive Officer
415-323-5252
https://www.linkedin.com/in/viswacolluru/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved